[HK IPO Subscription] Zhipu, Jingfeng Medical, Tianshu Zhixin, MINMAX, Ribobio, OmniVision Group. So many new stocks being subscribed at the same time, there must be something fishy.

It's really the end of the year, and the Hong Kong Stock Exchange is also pushing for performance. There are currently 10 new stocks being offered simultaneously, and tomorrow, Zhipu, Jingfeng Medical-B, and Tianshu Zhixin will close their offerings...

These three conflict with MINMAX-WP, Jinxun Resources, and Ruibo Biological-B, but the latter three also conflict with Howe Group...

Brother Er Gou will first share the IPO strategy for these 7 new stocks with everyone. Of course, this is just Brother Er Gou's personal opinion and his own investment record, not any investment advice. Please consider carefully on your own....

1. $KNOWLEDGE ATLAS(02513.HK): Along with Moon's Dark Side, Baichuan Intelligence, and MiniMax, it is known as one of the four domestic AI large model leaders. The newly released GLM-4.7 by Zhipu has shown outstanding performance in programming capabilities, ranking first in the Vals Index for open-source models. The company's last financing round was in May 2025, with a valuation of 24.4 billion RMB (equivalent to 27.2 billion HKD). This IPO has a market cap of 51.8 billion HKD, a 90% increase. The valuation isn't cheap, but the certainty is quite high....

2. $EDGE MEDICAL-B(02675.HK): Focuses on the R&D, production, and commercialization of minimally invasive surgical robots. Its core products cover multi-port, single-port, and bronchoscopy surgical robots. It is the first in China and the second globally to receive NMPA approval in these three areas. The last private financing round was in December 2021, with a valuation of approximately 1.507 billion USD (about 11.728 billion HKD). The IPO pricing corresponds to a market cap of about 16.765 billion HKD. Brother Er Gou plans to participate.

3. $ILUVATAR COREX(09903.HK): A leader in domestic general-purpose GPUs, it is the first in China to achieve dual mass production of training + inference general-purpose GPUs using 7nm technology. Along with Moore Threads, MuXi, and Biren Technology, it is known as one of the four domestic GPU leaders. The other three have already gone public... Even Biren Technology, with the smallest increase, has risen over 70%...

4. $MINIMAX-WP(00100.HK): Like Zhipu, it is one of the four domestic AI large model leaders, so the certainty is basically the same as Zhipu, and the two are at the same level....

5. $JINXUN RESOURCE(03636.HK): The company's core business is integrated mining, beneficiation, and smelting of African copper mines and cathode copper production. In 2024, it ranked fifth among Chinese cathode copper producers in the Democratic Republic of the Congo (DRC) and Zambia, the only Chinese company in the top five in both countries. It is the top private enterprise in Zambia and the third in the DRC... Those with mines aren't bad, but the sponsor is actually Zha Zha Tai, which is a real drawback...

6. $RIBOLIFE-B(06938.HK) B: A leader in small nucleic acid siRNA drug R&D, focusing on RNA interference technology and chronic diseases. Its core advantages include an independent liver-targeted delivery platform and globally pioneering clinical pipelines. Currently, it mainly earns from technology licensing and collaborations and is advancing the commercialization of multiple Phase II siRNA products. Innovative drugs with a B are a bit risky now, prone to sharp rises and falls, with low certainty...

7. $OMNIVISION(00501.HK): A secondary listing, originally Will Semiconductor in A-shares, now renamed. With so many new stocks and limited funds, second-marriage stocks aren't very interesting, so I won't participate....

To summarize Brother Er Gou's ranking for these new stocks: Tianshu Zhixin > Zhipu = MINMAX-WP > Jingfeng Medical > Jinxun Resources > Ruibo Biological-B > Howe Group

Finally, let's talk about Brother Er Gou's three account subscription plans:

1. Largest account: Margin trading for Tianshu Zhixin, with some cash for Jingfeng Medical and Jinxun Resources.

2. Second-largest account: Margin trading for Zhipu, with some cash for Jingfeng Medical and Jinxun Resources.

3. Third-largest account: Margin trading for Jingfeng Medical, with cash for Jinxun Resources and Ruibo Biological-B.

With so many new stocks, you have to give up some to gain others!

Finally, I wish everyone success in the new stock lottery, and may all subscriptions surge!!!

Follow Brother Er Gou for a smooth ride in HK IPO subscriptions~~

Disclaimer:

1. This article represents only personal opinions and is not any investment advice or recommendation. The stock market is unpredictable, with ups and downs, so caution is needed.

2. When making any investment decisions or transactions, please act within your means, handle calmly based on your financial situation, or consult professional investment institutions.

3. If you find this article interesting, likes, comments, and shares are welcome. The author would be very grateful.